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OMMENT
omment on ‘‘Pulmonar collision tumor’’
nd ‘‘Well-differentiated fetal adenocarcinoma’’
omentário a ‘‘Tumor pulmonar de colisão’’ e ‘‘Adenocarcinoma fetal bem
iferenciado’’
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fnatomia Patológica, Hospitais da Universidade de Coimbra, C
lanco et al. from Vigo1 and Ouazzani e al. from Rabat2 show
ow Bronchial-Pulmonary Carcinomas are dealt with nowa-
ays. They discuss the cases of a 38 years old woman with
very rare Well Differentiated Fetal Adenocarcinoma (the
nique carcinoma referred with a differentiation grade in
he WHO 2004 Classiﬁcation of lung tumors) and a 56 years
ld man presenting two metastasis of a right maxillary sinus
denoid Cystic Carcinoma after a gap of 11 years. These two
ases are reviewed in parallel with a Pleomorphic Carcinoma
f the lung (WHO 2004 -- glandular neoplastic proliferation
- Adenocarcinoma -- with large cells with severe atypi-
al cytology -- with pleomorphic elements), which required
mmunohistochemistry for correct diagnosis and carcino-
enic understanding. It is fortunate that surgical specimens
ive Modern Pathology an open laboratory so that the con-
equences of carcinogenic stimulation can be understood
- nothing happens by chance -- and the prognosis arrived
t by a combination of morphology, immunostaining, molec-
lar actual validation and pTNM, under the Pathologist’s
upervision.Embryology and adult potential stem cells expressions
re now recognised as research tools in the interpretation
f the histopathology of all benign and malignant tumors
nd the two examples under consideration, were obviously
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iagnosed based on fetal mimicking morphology which,
ogether with multiple speciﬁc different patterns correlated
ith different immonohistochemical speciﬁcities in the ﬁrst
ase, and in the second case, the expressions of TTF1/NKX:
he latter is a gene related to brain/thyroid/lung embryolog-
cal development and the c-kit gene, which is compromised
f stem cells maturity/proliferation which gives a diagnosis
etween two different carcinomas in the same lung, primary
nd metastatic.
The above mentioned exercise requested of Patholo-
ists is easily performed on surgical specimens as stated
bove which means that there is sufﬁcient experience and
cquired knowledge to be able to reliably apply well known
orphology/patterns and classiﬁcation language to small
iopsies. 70% of the bronchial-pulmonary carcinomas will
ave disseminated by the time of the diagnosis and biopsies
r cytology/cell blocks are available to a certain panel of
mmunohistochemistry and are up to the standard required
or Molecular Pathology.
Everything that has been achieved in the last 50 years
ased on morphology, electron miocroscopy and immunohis-
ochemistry on bronchial-pulmonary carcinomas now has to
e applied to routine Pathology; the Pathologist is expected
o recognise acinar, microacinar, papillary, micropapillary,
gia. Published by Elsevier España, S.L. All rights reserved.
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or Clara cells pattern (which used to be called lepidic
growth) from large/giant/spindle vimentin expressing cells
in pleomorphic/sarcomatoid carcinomas, followed by TTF1
negative expression in carcinomas of smoking patients
(without CK5.6 expression) needing KRAS mutation search
(beyond EGFR mutational status) to direct personalized
therapy in central/hilum adenocarcinomas, and even deal
with a 2mm2 biopsy where a secondary origin has to be
identiﬁed!
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